Showing results (111-120 of 132) with videos related to

Sort By:
Pageof 14
Brain, Behavior, and Immunity|July 25, 2018
The concerted amyloid-beta clearance of LRP1 and ABCB1/P-gp across the blood-brain barrier is linked by PICALMSteffen E Storck, Anika M S Hartz, Jessica Bernard, et al.
Journal of Bodywork and Movement Therapies|March 6, 2022
Relationship between osteopathic manipulative treatment of the temporomandibular joint, molar shim and the orthostatic position: A randomized, controlled and double blinded studyR Detoni, C S Hartz, E L Fusatto, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 5, 2009
Targeting prostaglandin E2 EP1 receptors prevents seizure-associated P-glycoprotein up-regulationAnton Pekcec, Bernadette Unkrüer, Juli Schlichtiger, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 23, 2019
Inhibition of human microsomal PGE2 synthase-1 reduces seizure-induced increases of P-glycoprotein expression and activity at the blood-brain barrierEmma L B Soldner, Anika M S Hartz, Shin-Ichi Akanuma, et al.
Frontiers in Aging Neuroscience|October 11, 2017
Age Drives Distortion of Brain Metabolic, Vascular and Cognitive Functions, and the Gut MicrobiomeJared D Hoffman, Ishita Parikh, Stefan J Green, et al.
Frontiers in Aging Neuroscience|August 25, 2018
Neuroimaging Biomarkers of mTOR Inhibition on Vascular and Metabolic Functions in Aging Brain and Alzheimer's DiseaseJennifer Lee, Lucille M Yanckello, David Ma, et al.
Gut|June 13, 2003
Mortality study of 18 000 patients treated with omeprazoleD N Bateman, D Colin-Jones, S Hartz, et al.
Journal of Visualized Experiments : Jove|October 2, 2018
Isolation of Cerebral Capillaries from Fresh Human Brain TissueAnika M S Hartz, Julia A Schulz, Brent S Sokola, et al.
Scientific Reports|May 28, 2021
Complex network model indicates a positive effect of inspiratory muscles pre-activation on performance parameters in a judo matchCarolina Cirino, Claudio A Gobatto, Allan S Pinto, et al.
The British Journal of Dermatology|May 26, 2017
Comparison of ixekizumab with ustekinumab in moderate-to-severe psoriasis: 24-week results from IXORA-S, a phase III studyK Reich, A Pinter, J P Lacour, et al.
Pageof 14